Improving breast cancer treatment in Nigeria
Official title: Improving Adherence to Breast Cancer Treatment Guidelines in Nigeria
Funded at Icahn School of Medicine at Mount Sinai · NIH-10917147 · Data updated 2026-11-12
This study is working to make breast cancer care better in Nigeria by helping doctors follow important treatment guidelines, so that women with breast cancer can get the best care possible, even in places with fewer resources.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $198,811 |
| NIH project number | 5K08CA267308-03 |
| Project ID | NIH-10917147 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with breast cancer in Nigeria who are seeking effective treatment options.
✕Less likely to help
Patients outside of Nigeria or those with breast cancer who are already receiving guideline-concordant care may not benefit from this research.
What this research studies
This research focuses on enhancing the delivery of breast cancer care in Nigeria by improving healthcare providers' adherence to established clinical practice guidelines. It aims to develop and evaluate strategies that ensure effective treatment is accessible to patients, particularly in resource-limited settings. The project will assess the implementation of the National Comprehensive Cancer Network (NCCN) Harmonized Guidelines, which are designed to provide evidence-based care tailored to the local context. By addressing barriers to guideline adherence, the research seeks to improve patient outcomes and survival rates for women with breast cancer.
Why it matters
Potential benefit: If successful, this research could lead to better breast cancer treatment outcomes for women in Nigeria by ensuring they receive guideline-concordant care.
How similar studies have gone: Previous research has shown that implementing structured guidelines can significantly improve treatment outcomes in similar healthcare settings.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Romanoff, Anya — Icahn School of Medicine at Mount Sinai
- Study coordinator: Romanoff, Anya
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.